Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
doi:10.1378/chest.07-0079
(Chest. 2008; 133:271-280)
© 2008 American College of Chest Physicians
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v133,p832)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swigris, J. J.
Right arrow Articles by Brown, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swigris, J. J.
Right arrow Articles by Brown, K. K.
Related Content
Right arrow Special Features

Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus*

Jeffrey J. Swigris, DO, MS; Aryeh Fischer, MD; Joann Gilles, MD; Richard T. Meehan, MD and Kevin K. Brown, MD, FCCP

* From the Autoimmune Lung Disease Center; National Jewish Medical and Research Center; Denver, CO.

Correspondence to: Jeffrey J. Swigris, DO, MS, Autoimmune Lung Center, National Jewish Medical and Research Center, 1400 Jackson St #G011, Denver, CO 80206; e-mail: swigrisj{at}njc.org

Abstract

Systemic lupus erythematosus (SLE) is considered the archetypal systemic autoimmune disease. Clinically characterized by multisystem involvement and varied serologic abnormalities, no two patients present or have disease that evolves in exactly the same way. Viewed histologically, SLE is characterized by some combination of inflammation and fibrosis, and the clinical phenotype is dictated by the relative contributions of each and the organs affected. Tissue injury appears to be mediated by characteristic autoantibody production, immune complex formation, and their organ-specific deposition. As expected in a multisystem disease, the entire pulmonary system is vulnerable to injury. Any of its compartments—airways, lung parenchyma, vasculature, pleura, or the respiratory musculature—may be independently or simultaneously affected. This article offers the reader a comprehensive review of the numerous pulmonary and thrombotic manifestations of SLE and suggests approaches to their management.

Key Words: lung • systemic lupus erythematosus • thrombosis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Chest Physicians.